EUVIMEDEUVIMED entdecken
Crossref

Nanotechnology in Cancer Immunotherapy

Samiksha P Warke Samiksha P Warke, Sandip W Patil Sandip W Patil, Patel Anas Patel Anas, Momin Rijwan Momin Rijwan

International Journal of Creative and Open Research in Engineering and Management · 26.05.2026 · 02 (05) · 1-4

DOI: 10.55041/ijcope.v2i5.774 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Creative and Open Research in Engineering and Management, online erschienen am 26.05.2026. Verfasst von Samiksha P Warke Samiksha P Warke und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer immunotherapy has emerged as a promising approach for cancer treatment by stimulating the body’s immune system to recognize and destroy cancer cells. However, limitations such as poor drug targeting, immune suppression, and systemic toxicity reduce its effectiveness. Nanotechnology offers innovative solutions to these challenges through the use of nanoparticles and nanocarriers for targeted drug delivery and immune modulation. Nanoparticles such as liposomes, dendrimers, polymeric nanoparticles, and metallic nanoparticles improve the delivery of immunotherapeutic agents including checkpoint inhibitors, cancer vaccines, cytokines, and gene therapies. These systems enhance drug stability, increase tumor-specific accumulation, and reduce adverse side effects. Nanotechnology also improves antigen presentation and activation of immune cells such as T-cells and dendritic cells. Recent advancements in nano-based vaccines, gene delivery systems, and tumor microenvironment-responsive nanoparticles have shown significant potential in improving therapeutic outcomes. Despite these advantages, challenges including toxicity, large-scale production, and regulatory approval remain. This paper reviews the role of nanotechnology in cancer immunotherapy, its mechanisms, applications, advantages, limitations, and future prospects in modern cancer treatment. Keywords: Nanotechnology, Cancer Immunotherapy, Nanoparticles, Drug Delivery, Tumor Microenvironment, Nano-vaccines

Zitieren

APA

Warke, S. P. W. S. P., Patil, S. W. P. S. W., Anas, P. A. P., & Rijwan, M. R. M. (2026). Nanotechnology in Cancer Immunotherapy. International Journal of Creative and Open Research in Engineering and Management, 02(05), 1-4. https://doi.org/10.55041/ijcope.v2i5.774

Vancouver

Warke SPWSP, Patil SWPSW, Anas PAP, Rijwan MRM. Nanotechnology in Cancer Immunotherapy. International Journal of Creative and Open Research in Engineering and Management. 2026;02(05):1-4. doi:10.55041/ijcope.v2i5.774

BibTeX
@article{Warke2026,
  author = {Warke, Samiksha P Warke Samiksha P and Patil, Sandip W Patil Sandip W and Anas, Patel Anas Patel and Rijwan, Momin Rijwan Momin},
  title = {Nanotechnology in Cancer Immunotherapy},
  journal = {International Journal of Creative and Open Research in Engineering and Management},
  year = {2026},
  volume = {02},
  number = {05},
  pages = {1--4},
  doi = {10.55041/ijcope.v2i5.774}
}
Kostenlos starten →